Intestinal absorption and metabolism of prostaglandin E1−1−14C by thoracic duct and bile duct cannulated rats

Intestinal absorption and metabolism of prostaglandin E1−1−14C by thoracic duct and bile duct cannulated rats

Life Sciences Vol. 7, Part I, pp. 883-889, 1988. Printed in Great Britain . Pergamon Press INPESTINAL ABSORPTION AND METABOLISM OF PROSTAGLANDIN Ey-...

224KB Sizes 0 Downloads 19 Views

Life Sciences Vol. 7, Part I, pp. 883-889, 1988. Printed in Great Britain .

Pergamon Press

INPESTINAL ABSORPTION AND METABOLISM OF PROSTAGLANDIN Ey-1-14C BY THORACIC DUCT AND BILE DUCP CANNULATED RATS T . M. Parkinson, .J . C . Schneider, Jr ., J . J . Krake and W. L. Miller Metabolic Diseases Research, The Upjohn Compar~y, Kalamazoo, Michigan

b9001

(Received 3 Niay 1968; in final form 7 June 1968) ALTHOUGH several studies have been published on the metabolism of parenterally administered 14C- or 3Ii-labelled prostaglandin E1

(PGEy), corresponding data

on the metabolism of orally administered compound have not been reported previously .

20

Samuelsson (1) foiu.d that

PGE1-5,6-3Ii

hours after intravenous infusion of

to rats, about 50~ of the isotope was recovered in the urine as

more polar metabolites and 10~, was recovered in the feces .

In man, after

intravenous administration, 3Ii-labelled PGEl disappeared rapidly from the blood and was excreted in the urine

(60~)

and feces

(40y6) (2) .

When PGEy-1-C1~ was

constantly infused into fed rats via an indwelling jugular tannins, ity was exhaled as 14C0 2 at a maximum rate of

4996

radioactiv-

of the infusion rate ; in

animals fasted for 15 hours prior to dosing, rate of expired 14 C0 2 production was

68',b

of the infusion rate (3) .

About

recovered in the urine of a fed rat in

72

7-8'~6

of the infused radioactivity was

hours (3) .

In the present study rata

with thoracic duct or bile duct cannulas housed in a metabolic chamber were given FGE1-1-14 C dissolved in cottonseed oil orally via stomach tube and 14C02 in expired air as well as radioactivity in lymph or bile were measured over the next

24

hours . Materials and Methods

Thoracic ducts of fed male rats

(Sprague-Dawley, Upjohn strain) weighing

approximately 300 g were cannulated with polyethylene tubing (Intramedic PE

60,

Clay-Adams, Inc ., New York) using modifications of the procedure of Bollman et al . (4) .

Animals were placed in restraining cages without food but with free

883

Vol. 7, No . 15

PROSTAGLANDIN

884

access to 0 .996 saline and 16-20 hours later were given by s1_omach tube 0 .7-1 .0 ml cottonseed oil (Wesson Sales Co ., Fullerton, Calif .) containing 1 .2~ WC PGE1-1- 14 C per ml (specific activity

WC~mg)(5) .

j .~Fl

The animals were placed

in a glass metabolic chamber (Aerospace Industries, Inc ., Garnersville, N . Y .) and the chamber was connected to a Bio-Monitor (Beckma.n Instruments, Inc ., Medical Systems Operations, Fullerton, Calif .) which measured total exhaled C02, total 14C02, and calculated the specific activity of exhaled C02 .

Total

C02 was measured by a thermal conductivity detector and radioactive C0~ was measured by a vibrating-reed electrometer .

Lsymph was collected at l, 3, j, 12

and 24 hours in glass tubes containing 0 .5 ml of heparin in saline (Upjohn, 1000 units~ml) .

One-tenth ml of lymph from each collection period was counted

in 10 ml of naphthalene-dioxane scintillation fluid (6) in a Tri Carb (Packard Instrument Sales Corp ., Cleveland, Ohio) scintillation spectrometer .

Absolute

sample activities were determined using a toluene- 14 C internal standard .

Ali-

quots of 24-hour pooled Lymph collections were extracted with 1-butanol or 80$ aqueous ethanol (1) and extracts were chromatographed on Silica Gel G plates in chloroform-methanol-acetic acid (90 :5 :5) .

Spots were detected by heating

the plates to 120 ° and spraying with 1096 phosphomolybdic acid in absolute ethanol and were scraped off the plates into vials and counted in 10 ml diotol scintillation fluid (7) . Results Average specific activity in expired air for two rats in shown in Fig . 1 . Radioactivity appeared in the breath rapidly after dosing and maximum specific activity was measured within 50-40 minutes .

Specific activity then fell so

rapidly that by the end of hour 2 the initial peak was complete and accounted for about 15$ of the administered dose .

A second peak began to form between

hour 3 and hour 4 and reached a maximum by hour 7.

This second peak was com-

plete by hours 10-12 and contained about 1~+~, of the administered radioactivity . Peaks 1 and 2 accounted For about >096 of the total expired l 'C02, or about 2~

Vol. 7, No . 15

PROSTAGLANDIN

885

FIG . 1

40

35

N U N U a

30

25

z r

20

a

15

U

U W a N

10

5

Q lvvv

0

2

.

4

.vvv

6

8

10

W-

12

16 20 HOURS AFTER ORAL DOSE OF PGE~-I-~ 4 C

%rcretion of 14 C0~ irr "_xpix~e:l air aftc?~ oral administration of PGLl-1- l ''C '. .o thoracic tract car:nuJcrtc " d rats . Data are the at~era.gen cf two r~ri .mals . cl' t. } :e administered dosa .

!üt additio?ra.l : ;,x!~ of '. : :re dose "aas accounted for by a

rat.lter con;i.ara. rate of ~"xcretion of l''CC ; : trp to :rct:rc l'(-20 .

Radioactivity in

2'a-hour ly-tnplr scruples accounted for G .'i-i .0~~ ci' ±!,~, adn:ir:ist .ei~ed donc" (Table 1) .

Specific activil.y of collF_cte.3 iy?nç~a (dhr::/n.l .

react:c d a rna:timu:n ~-12 trouts

after dosing anà remained relaatinely con tan' . dr.rir :ë, n.l :e rest of tl .v collection period .

'TLC of ly???plr ext!~ac+. :~ d~_tec ; .e~i r:o ccr??por :+ :rrts wi`.I : ' . .,_ Mine Rf. a~ PGE1

or PG/11 star~dar :ds ci .rcn?a.tol :ral~:,~ :~: ::ir. :ua~:arx ;r ; : . .!y .

i~:l .i" r~ ao PGE1 xnd PCA1 t,av~

886

PROSTAGLANDIN

U

ro

rl

q O N +~ N

U o0

tD

i+ q N rl

N1

~

O .-i

lf\

ti

ti

0 q 0 *-I +~

ô

m ,~ q ,-I Fi

O

.?

N

N rl

fi N

O~

L In

~

~

O

U +> U ,-1 U mfi O W O

â q ,i ro

N 0 U

~i

U

fi N r-I I In

a

rn Ô

~+l ro

tn m Fa

m ro

v U

N

Q

m

O

a~

w

ro N

Vol . 7, No. 15

N r-I -?

L

N I

L

~n N y 3

F+ rn

O

~

O

:7~

rl

N

N

O~ -7

I a

ro N r-I m

m ti 0

v~

N

W

rl O

~+ rl

ô

~O

O

a Si

,i ,~ U O "rl

ro

O r-I

N

Kl

N rl

ai +~

H

PR06TAGLANDIN

Vol. 7, No . 15

887

Rf values in this system of 0 .35 and 0 .70, respectively, 95% of the radioactivity recovered from the TLC plates remained at origin, suggesting that 14 C from PGEl-1- 14C may have been incorporated into non-prostaglandin metabolites . Samuelsson (1) reported that rats given PGE1- 3fi intravenously excreted about 10~, of the radioactivity in the bile within 5 hours after dosing .

It

seemed possible, therefore, that peak 2 in expired 14 C0z could result from absorption and metabolism of radioactive products in the enterohepatic ciroulation derived from PGE1-1- 14C .

Expired C02 was analyzed from a rat given PGE1-

1-14C orally after bile duct cannulation .

Peak 2 did not occur in the 14 C02

profile of this animal ; 6~ of the administered dose of radioactivity was recovered in the bile in 24 hours (Fig . 2) .

A sample of the pooled 24-hour bile

FIG . 2

8

z ~~ o ,= 4

F E W Ô

X ~ W

~ 2 d

d

1/ L 1

0

2

1

1

4

1

1

6

1

1

8

1

1

1

1

1

10

12

16

20

24

HOURS AFTER ORAL DOSE OF PGE~-I-~ 4C

Excretion of 14 carbon in bile after oral administration of 1 .07 WC PGE1-1- 14 C . Bile samples (0 .05 ml) were counted in 10 ml naphthalene-dioxane scintillation fluid . collection was extracted with 1-butanol and the residue was chromatographed on Silica Gel G as described for lymph extracts . or PGA1 were detected .

No spots corresponding to PGE 1

Eighty-eight per cent of the radioactivity recovered

From the TLC plate remained at origin, flzrther suggesting incorporation into

PROSTAGLANDIN

888

Vol . 7, No . 15

non-prostaglandin metabolites . Discussion Miller and Krake (3) reported previously that PGEl-1- 14C was rapidly and extensively metabolized to 14 C02 during intravenous infusion .

In the present

study similar rapid excretion of radioactivity in expired air is seen after oral administration .

Harnberg and Samuelsson (8) ha "re found that rat liver

mitochondria degrade PGEl~and PGF ycx in vitro to their Cls homologs by one ßoxidation sequence .

Isolation of the Cla homolog of PGFy~ from urine after

administering the parent compound subcutaneously to rats (y) indicates that the prostaglandins are oxidized via this same pathway in vivo, as previously suggested by Granström, Inger and Samuelsson (9) .

Thus it 1s possible that PGFl-

1- 14 C given orally to thoracic duct cannulated rats was absorbed, carried to the liver in the portal blood, and subjected to ß-oxidation .

Acetate-l- l ~C

formed in these reactions could be oxidized further via the citric acid cycle to 14C02 or be incorporated into other metabolites .

However, the rapidity with

which radioactive C0 2 appeared in the breath after oral administration, and the presence of 14 C-labelled lipids in lymph also suggests the possibility that ßoxidation of PGE1 may take place in the intestine itself .

Indeed, preliminary

studies indicate that 14 C02 is produced by rat jejunum perfused with PGEl-1- 14 C in vitro and that radioactivity is incorporated into both the saponifiable and non-saponifiable fractions of tissue lipids (Parkinson and Schneider, to be published) . Summary Approximately 58',~ of a dose of PGE1-1- 14 C administered orally to thoracic duct cannulated rats was excreted as 1 ~C02 in expired air in 24 hours ; an additional O .j-5 .0$ was found in thoracic duct lymph .

About ~0~6 of the radio

activity in expired air was accounted for in two peaks of maximum specific activity occurring 30-ü0 minutes and ~-7 hours after dosüig .

The second peak

PROSTAGLAI~IN

Vol. 7, No. 15

889

did not occur in the 14 C02 profile of a bile duct cannulated rat and may represent metabolism of radioactive products in the enterohepatic circulation derived from PGE1-1-14 C . References

~, 4091 (1964) .

1.

B . SAMUEISSON, J . Biol . Chem .

2.

E . GRANSTROM, Progr . Biochem. Pharmacol.

3.

W . L . MILLER and J . J . KRAKE, Federation Proc .

4.

J . L . BOLLMAN, J . C . CAIN and J . A. GRINDLAY, J . Isb . Clin . Med .

5.

W . P. SCHNEIIIER, J . E . PIKE and F . P . KUPIECKI, Biothun . Biophys . Acta

6.

J . A . BRAY, Anal . Biochez

1,

7.

R . J . HARBERG, Anal . Chem .

~2, 42 (1960) .

8. 9.

~, 89 (1967) . ~, 241 (1968) .

(1948) .

~, 1349

611 (1966) .

279 (1960) .

M. HAMBERG and B . SAMUEISSON, to be presented before the Federation of European Biochemical Societies, Prague, July, 1968 . a E . GRANSTROM, V. INGER and B . SAMUELSSON, J . Biol . Chem . 240,

457 (1965) .